Not for Human Consumption - Research Purposes Only
Gender-specific considerations when using BPC-157 in fertility plans include: Female: Timing with menstrual cycle impacts endometrium and implantation window
Secondary endpoints included the proportion of participants achieving 5% and 10% body weight reduction, absolute weight change in kg, change in waist circumference, lipid parameters including total cholesterol, HDL, LDL, VLDL, triglycerides, and glycaemic variables such as HbA1c, fasting glucose, insulin, HOMA-IR, and -cell function
Athletes competing in sports with active anti-doping programs should note that Thymosin Beta-4 analogs appear on the WADA Prohibited List under S2
10.1016/j.pbiomolbio.2008.05.007 122 CottonA